<DOC>
	<DOCNO>NCT00254735</DOCNO>
	<brief_summary>The purpose study evaluate efficacy quetiapine placebo add baseline treatment SSRI/clomipramine treatment OCD adult subject .</brief_summary>
	<brief_title>Quetiapine Augmentation Severe Obsessive Compulsive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Clomipramine</mesh_term>
	<criteria>Signed informed consent , men woman age ³18 £65 year diagnosis OCD , least 12 week treatment SSRI clomipramine Substance abuse dependence , female patient pregnant , lactate risk pregnancy , know intolerance lack response quetiapine , use antihypertensive medication change dos</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Obsessive Compulsive Disorder ( OCD )</keyword>
</DOC>